Identification of Natural Molecular Determinants of Ross River Virus Type I Interferon Modulation.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
31 03 2020
Historique:
received: 17 10 2019
accepted: 24 01 2020
pubmed: 31 1 2020
medline: 29 9 2020
entrez: 31 1 2020
Statut: epublish

Résumé

Ross River virus (RRV) belongs to the genus

Identifiants

pubmed: 31996431
pii: JVI.01788-19
doi: 10.1128/JVI.01788-19
pmc: PMC7108833
pii:
doi:

Substances chimiques

Antiviral Agents 0
Cytokines 0
Interferon Type I 0
Viral Nonstructural Proteins 0
Viral Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

J Virol. 1993 Jun;67(6):3576-85
pubmed: 8497065
J Gen Virol. 1981 Jul;55(Pt 1):109-16
pubmed: 6170723
J Virol. 2007 Apr;81(8):3866-76
pubmed: 17267491
J Virol. 1981 Aug;39(2):348-58
pubmed: 7277580
Virology. 1995 Sep 10;212(1):20-9
pubmed: 7676630
J Virol. 2007 Aug;81(16):8677-84
pubmed: 17553895
Science. 2014 Feb 14;343(6172):783-7
pubmed: 24482115
J Virol. 2006 Jan;80(2):737-49
pubmed: 16378976
J Virol. 1993 Jun;67(6):3605-10
pubmed: 8388513
J Virol. 1996 May;70(5):2706-19
pubmed: 8627744
Virology. 2010 Mar 30;399(1):1-10
pubmed: 20097400
J Exp Med. 2010 Feb 15;207(2):429-42
pubmed: 20123960
Viruses. 2016 Jun 11;8(6):
pubmed: 27294951
J Gen Virol. 2008 Mar;89(Pt 3):676-686
pubmed: 18272758
Virology. 1999 Apr 25;257(1):106-18
pubmed: 10208925
Annu Rev Entomol. 2002;47:1-31
pubmed: 11729067
Int Rev Immunol. 2002 Jul-Oct;21(4-5):305-37
pubmed: 12486817
J Virol. 1989 Mar;63(3):1194-202
pubmed: 2521674
Arch Virol Suppl. 1994;9:369-77
pubmed: 8032268
J Virol. 2015 Mar;89(6):3145-62
pubmed: 25552719
PLoS Pathog. 2013;9(9):e1003610
pubmed: 24039580
Virology. 1983 Aug;129(1):170-87
pubmed: 6310876
J Virol. 2014 Apr;88(7):3719-32
pubmed: 24429363
PLoS Pathog. 2008 Feb 8;4(2):e29
pubmed: 18282093
J Virol. 2002 Nov;76(22):11254-64
pubmed: 12388685
J Virol. 2012 Jul;86(13):7180-91
pubmed: 22514352
New Microbiol. 2011 Jan;34(1):87-91
pubmed: 21344151
Nat Rev Immunol. 2012 Jan 06;12(2):125-35
pubmed: 22222875
J Virol. 2010 Nov;84(21):11429-39
pubmed: 20739538
mBio. 2018 Aug 21;9(4):
pubmed: 30131356
EMBO Mol Med. 2014 Dec 01;7(1):24-41
pubmed: 25452586
J Virol. 2011 Jun;85(11):5651-63
pubmed: 21430046
Emerg Infect Dis. 2019 Apr;25(4):827-830
pubmed: 30882332
J Virol. 2007 Dec;81(24):13509-18
pubmed: 17928353
J Virol. 2006 Mar;80(5):2396-404
pubmed: 16474146
J Virol. 2007 Jan;81(1):237-47
pubmed: 17079324
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12048-53
pubmed: 21730129
J Virol. 2018 Aug 16;92(17):
pubmed: 29925658
J Virol. 1991 Feb;65(2):985-8
pubmed: 1824787
Clin Microbiol Rev. 2001 Oct;14(4):909-32, table of contents
pubmed: 11585790
J Virol. 2012 May;86(9):5055-66
pubmed: 22345447
Virology. 2007 Nov 25;368(2):273-85
pubmed: 17681583
J Exp Med. 1998 Jun 1;187(11):1799-811
pubmed: 9607921
Virology. 2000 Oct 10;276(1):93-103
pubmed: 11021998
J Virol. 2013 Sep;87(18):10394-400
pubmed: 23864632
J Virol. 2010 Oct;84(20):10877-87
pubmed: 20686047
Adv Appl Microbiol. 2010;73:83-101
pubmed: 20800760
J Gen Virol. 2003 Jun;84(Pt 6):1525-1533
pubmed: 12771422
J Virol. 2019 Feb 5;93(4):
pubmed: 30487275
J Virol. 2000 Apr;74(7):3366-78
pubmed: 10708454
Virology. 1991 Jun;182(2):430-41
pubmed: 1673812
J Virol. 2007 Oct;81(20):11246-55
pubmed: 17686841
Virology. 1985 Jul 15;144(1):20-34
pubmed: 4060589
J Virol. 2001 Apr;75(8):3706-18
pubmed: 11264360
Science. 1994 Jun 24;264(5167):1918-21
pubmed: 8009221
J Virol. 2009 Oct;83(20):10571-81
pubmed: 19656875
Biotechnol Bioeng. 2005 Jun 30;90(7):793-804
pubmed: 15834946
Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11284-8
pubmed: 7479980
Aust Fam Physician. 2009 Aug;38(8):586-9
pubmed: 19893779
J Virol. 2012 Sep;86(18):9888-98
pubmed: 22761364
J Infect Dis. 2000 Jan;181(1):27-34
pubmed: 10608747
Arch Virol. 1979;60(3-4):249-55
pubmed: 228636
J Virol. 2000 Sep;74(18):8376-81
pubmed: 10954537
J Virol. 2018 Nov 12;92(23):
pubmed: 30232189
J Virol. 2016 Sep 12;90(19):8478-86
pubmed: 27440879
J Virol. 2015 Oct;89(20):10637-47
pubmed: 26269187
J Interferon Cytokine Res. 2010 Dec;30(12):875-81
pubmed: 21121861

Auteurs

Xiang Liu (X)

Institute for Glycomics, Griffith University, Southport, Queensland, Australia.
Menzies Health Institute Queensland, Griffith University, Southport, Queensland, Australia.

Margit Mutso (M)

Institute for Glycomics, Griffith University, Southport, Queensland, Australia.
Menzies Health Institute Queensland, Griffith University, Southport, Queensland, Australia.

Liubov Cherkashchenko (L)

Institute of Technology, University of Tartu, Tartu, Estonia.

Eva Zusinaite (E)

Institute of Technology, University of Tartu, Tartu, Estonia.

Lara J Herrero (LJ)

Institute for Glycomics, Griffith University, Southport, Queensland, Australia.

Stephen L Doggett (SL)

Department of Medical Entomology, Pathology West, ICPMR, Westmead Hospital, Westmead, NSW, Australia.

John Haniotis (J)

Department of Medical Entomology, Pathology West, ICPMR, Westmead Hospital, Westmead, NSW, Australia.

Andres Merits (A)

Institute of Technology, University of Tartu, Tartu, Estonia.

Belinda L Herring (BL)

Institute for Glycomics, Griffith University, Southport, Queensland, Australia.

Adam Taylor (A)

Institute for Glycomics, Griffith University, Southport, Queensland, Australia.
Menzies Health Institute Queensland, Griffith University, Southport, Queensland, Australia.

Suresh Mahalingam (S)

Institute for Glycomics, Griffith University, Southport, Queensland, Australia s.mahalingam@griffith.edu.au.
Menzies Health Institute Queensland, Griffith University, Southport, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH